Company
IDT Australia Limited
Headquarters: Boronia, VIC, Australia
CEO: Dr. David Sparling L.L.B., BVSc (Hons), GDipAppCGov, LLB (Hons)
Market Cap
A$36.9 Million
AUD as of Jan. 1, 2024
US$25.1 Million
IDT Australia Limited Categories
Australia Healthcare Drug Manufacturers—Specialty & GenericAustralia Healthcare Australia Drug Manufacturers—Specialty & Generic
Top Competitors by Market Capitalization
Industry: Drug Manufacturers—Specialty & Generic
| Company | Market Cap (USD) |
|---|---|
| Zoetis Inc. | $89.09 B |
| MERCK Kommanditgesellschaft auf Aktien | $67.64 B |
| Takeda Pharmaceutical Company Limited | $47.71 B |
| Haleon plc | $38.90 B |
| PPD, Inc. | $16.58 B |
Sector:
| Company | Market Cap (USD) |
|---|---|
| Lilly | $586.39 B |
| UnitedHealth Group | $504.47 B |
| Novo Nordisk | $461.52 B |
| Johnson & Johnson | $387.50 B |
| Merck | $296.51 B |
Detailed Description
IDT Australia Limited researches, develops, manufactures, and sells active pharmaceutical ingredients (APIs) and finished dose form products in Australia and internationally. The company offers analytical method development, stability chambers, and chemistry and microbiology quality control laboratory services. Its services also include project management, chemical, analytical chemistry, pharmacy, clinical packaging, and regulatory affairs, as well as pharmaceutical development services in all dosage forms. In addition, the company offers medicinal cannabis products; and various contract manufacturing services. IDT Australia Limited was founded in 1975 and is headquartered in Boronia, Australia.
Top 1-year algo backtest: +269.94%
$10,000 in May 2023 would now be $36,994 by following this algorithm daily at market close.
Boost your stocks returns with Disfold AI... Now!
Try Disfold AI for FREE
Stocks & Indices
IDT Australia Limited has the following listings and related stock indices.
Stock: ASX: IDT wb_incandescent